Prostate cancer trials in China

In China 252 Also abroad 1481

252 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

Phase 2Not yet taking people in China
Diagnostic Performance of ACP3-Targeted PET Imaging in Patients With Primary and Recurrent Prostate Cancer: An Open-Label, Single-Arm, Single-Center Study
Where
Wuhan
Age
18 years to 90 years
People
50
Run by
Yong He
See details and how to joinNCT07830212
Phase 2/3Taking people
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
Where
Beijing, Chengdu, Fuzhou, Guangzhou, Nanjing, Shanghai, Shenyang, Tianjin, Wuhan, Xian
Age
18 years to 100 years
People
443 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT06780670 · EU 2024-512342-42-00
Phase 1/2Taking people
A Study of HRS-5041 Tablets Combined With Antitumor Therapy in Subjects With Advanced Prostate Cancer
Where
Harbin, Shanghai
Age
18 years to 80 years
People
100
Run by
Jiangsu HengRui Medicine Co., Ltd.
See details and how to joinNCT06568094
Phase 3Taking people
This Study Evaluates the Diagnostic Performance and Safety of 68Ga-NYM032 PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer.
Where
Nanjing, Wuxi
Age
18 years and over
People
232
Run by
Norroy Bioscience Co., LTD
See details and how to joinNCT07649122
No phaseEnrolling by invitation
Development and Validation of a Non-Invasive AI Diagnostic Model for Prostate Cancer Using Multiparametric MRI and PSMA PET/CT
Where
Beijing, Guangzhou, Jinan, Shanghai
Age
18 years and over
People
1,500 worldwide
Run by
Xiangya Hospital of Central South University
See details and how to joinNCT07690306
No phaseNot yet taking people in China
Spatial Multi-Omics of Perineural Invasion Microenvironment and Prognosis in Prostate Cancer
Where
Hefei
Age
18 years to 85 years
People
120
Run by
Anhui Medical University
See details and how to joinNCT07818395
No phaseNot yet taking people in China
Intratumoral Microbiota and Immune Microenvironment in Prostate Cancer
Where
Hefei
Age
18 years and over
People
100
Run by
Anhui Medical University
See details and how to joinNCT07818421
Phase 2Not yet taking people in China
PSMA PET/CT-Guided SBRT Plus Darolutamide in mHSPC
Where
Chengdu
Age
18 years to 85 years
People
254
Run by
West China Hospital
See details and how to joinNCT07649421
Early phase 1Taking people
The Dosimetry, Safety and Diagnostic Efficacy of ⁶⁸Ga-FC516 in Healthy Subjects and Patients With Prostate Cancer
Where
Guangzhou
Age
18 years and over
People
10
Run by
FindCure Biosciences (ZhongShan) Co., Ltd.
See details and how to joinNCT07468708
No phaseTaking people
Prostate Specific Membrane Antigen PET/CT Imaging in PSMA-Related Disease Patients
Where
Hefei, Qingdao, Tianjin
Age
18 years to 80 years
People
500
Run by
Tianjin Medical University
See details and how to joinNCT06690970
Phase 1Taking people
A Multicenter, Open-label Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of SHR-6914 Injection in Participants With Prostate Cancer
Where
Guangzhou
Age
18 years to 80 years
People
118
Run by
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
See details and how to joinNCT07735377
Early phase 1Taking people
The Safety, Dosimetry and Efficacy of 177Lu-FC516 in Patients With Prostate Cancer
Where
Wuxi
Age
18 years and over
People
13
Run by
FindCure Biosciences (ZhongShan) Co., Ltd.
See details and how to joinNCT07542379
No phaseNot yet taking people in China
AI-Assisted Patient Support in mHSPC
Where
Fuzhou, Kunming, Shanghai, Wenzhou
Age
18 years to 80 years
People
160
Run by
Fudan University
See details and how to joinNCT07804030
Phase 2Taking people
A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
Where
Hangzhou, Huaian, Shanghai, Tianjin, Yangzhou
Age
18 years and over
People
218 worldwide
Run by
Astellas Pharma Global Development, Inc.
See details and how to joinNCT07005154 · EU 2024-517653-27-00
Phase 1/2Taking people
A Study to Learn How Safe AZD6621 is, How Well it Works, and How it Moves Throughout the Body Over Time, in Adult Male Participants With Metastatic Prostate Cancer
Where
Beijing, Chengdu, Guangzhou, Nanjing
Age
18 years and over
People
52 worldwide
Run by
AstraZeneca
See details and how to joinNCT07192614 · EU 2025-520626-37-00
Early phase 1Taking people
Clinical Evaluation of SRT-017 in Patients With PSMA-Positive Metastatic Castration-Resistant Prostate Cancer
Where
Wuxi
Age
18 years and over
People
18
Run by
Affiliated Hospital of Jiangnan University
See details and how to joinNCT07798778
Phase 1Taking people
Study of HRS-5041 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)
Where
Shanghai
Age
18 years to 80 years
People
100
Run by
Jiangsu HengRui Medicine Co., Ltd.
See details and how to joinNCT05942001
Phase 2Not yet taking people in China
A Prospective Study Based on Spatial Multi-omics to Predict the Efficacy of ADT Combined With Second-generation Novel Hormonal Agents in Metastatic Hormone-sensitive Prostate Cancer.
Where
Hefei
Age
18 years to 85 years
People
40
Run by
Anhui Medical University
See details and how to joinNCT07795177
No phaseTaking people
Ipsilateral Versus Bilateral Systematic Biopsy Combined With MRI/Ultrasound Cognitive Fusion Targeted Biopsy for Prostate Cancer Diagnosis
Where
Nanjing
Age
19 years and over
People
454
Run by
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
See details and how to joinNCT07795723
Phase 2Taking people
Prostate Cryoablation Combined With Metronomic Cyclophosphamide for Metastatic Prostate Cancer
Where
Guangzhou
Age
18 years to 80 years
People
104
Run by
Sun Yat-sen University
See details and how to joinNCT06854250
Phase 1Taking people
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
Where
Beijing, Guangzhou, Hangzhou, Nanchang, Nanjing, Shanghai, Wenzhou
Age
18 years and over
People
479 worldwide
Run by
Amgen
See details and how to joinNCT04221542 · EU 2023-504361-23-00
No phaseTaking people
Adjuvant Chemotherapy for High Malignant Prostate Cancer
Where
Baoding, Beijing, Shenzhen
Age
18 years to 80 years
People
315
Run by
Peking University First Hospital
See details and how to joinNCT06864533
No phaseTaking people
An Observational Study Conducted in China to Evaluate the Efficacy and Safety of Darolutamide in Combination With Androgen Deprivation Therapy (ADT) for Men With Non-metastatic Prostate Cancer That Progressed Following Prior Bicalutamide + ADT Treatment
Where
Multiple Locations
Age
18 years and over
People
800
Run by
Bayer
See details and how to joinNCT07538843
Phase 3Taking people
Investigating the Safety and Diagnostic Performance of 68Ga-NYM032 Injection PET/CT in Men With Newly Diagnosed Prostate Cancer.
Where
Nanjing, Wuxi
Age
18 years and over
People
365
Run by
Norroy Bioscience Co., LTD
See details and how to joinNCT07615101
No phaseTaking people
CytoREductive prostAtectomy for Poly-metastatic Hormone sensiTIVE Prostate Cancer
Where
Shanghai
Age
18 years to 85 years
People
192
Run by
RenJi Hospital
See details and how to joinNCT06306612